Kumar v. National Medical Enterprises, Inc.

42 F.3d 1400, 1994 U.S. App. LEXIS 39478, 1994 WL 659031
CourtCourt of Appeals for the Ninth Circuit
DecidedNovember 22, 1994
Docket93-16841
StatusUnpublished

This text of 42 F.3d 1400 (Kumar v. National Medical Enterprises, Inc.) is published on Counsel Stack Legal Research, covering Court of Appeals for the Ninth Circuit primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Kumar v. National Medical Enterprises, Inc., 42 F.3d 1400, 1994 U.S. App. LEXIS 39478, 1994 WL 659031 (9th Cir. 1994).

Opinion

42 F.3d 1400

1995-1 Trade Cases P 70,868

NOTICE: Ninth Circuit Rule 36-3 provides that dispositions other than opinions or orders designated for publication are not precedential and should not be cited except when relevant under the doctrines of law of the case, res judicata, or collateral estoppel.
Narendra KUMAR, M.D., Plaintiff-Appellant,
v.
NATIONAL MEDICAL ENTERPRISES, INC.; Scenic Faculty Medical
Group; William L. Boddie, M.D.; Martin S. Cohen, M.D.;
Ronald Goldman, M.D.; Maynard Rasmussen; M.D.; Robert
Watson, M.D.; and Richard Gratian, M.D., Defendants-Appellees.

No. 93-16841.

United States Court of Appeals, Ninth Circuit.

Submitted Nov. 14, 1994.*
Decided Nov. 22, 1994.

Before: WALLACE, Chief Judge, GOODWIN and NORRIS, Circuit Judges.

MEMORANDUM**

Narendra Kumar, M.D., appeals pro se the district court's summary judgment for defendants in his action alleging violations of the Sherman Act, 15 U.S.C. Secs. 1 and 2, and state law in relation to his loss of staff privileges at two hospitals. Kumar contends that the district court erred by (1) finding Kumar failed to establish a question of material fact regarding the existence of antitrust injury, (2) refusing to grant Kumar more time to pursue discovery prior to ruling on defendants' motions for summary judgment, and (3) ruling that Kumar's objections to the magistrate's findings and recommendations were untimely. We have jurisdiction pursuant to 28 U.S.C. Sec. 1291, and affirm.

* Background

Beginning in July 1982, Kumar practiced neonatal medicine in Modesto, California. He practiced at Scenic General Hospital ("Scenic") and Modesto City Hospital ("MCH"), the latter of which is the only hospital in Stanislaus County with an intensive care unit. Kumar was also a staff member of Scenic Faculty Medical Group, a group of doctors which provided services to Scenic General Hospital. On April 15, 1985 Kumar resigned as attending pediatrician and neonatologist at Scenic. Kumar retained staff privileges following his resignation but they expired after he chose not to renew them. In October 1985, Kumar's staff privileges at MCH were suspended and in November 1986 they were terminated.

In his second amended complaint filed on October 13, 1988, Kumar alleged that defendants conspired to make him lose staff privileges at Scenic and MCH so that they could restrain and monopolize the neonatal care business in Stanislaus County.

On June 30, 1993, following a hearing on defendants' motions for summary judgment, the magistrate judge issued his findings and recommendations. He concluded that summary judgment should be granted for the defendants because Kumar had failed to offer any evidence to establish an antitrust injury. On July 12, Kumar filed objections to the magistrate's findings and recommendations. On September 14, 1993, the district court ruled Kumar's objections were untimely, adopted the magistrate's findings and recommendations, and granted defendants' motions for summary judgment.

II

Merits

We review the district court's summary judgment de novo, McGuckin v. Smith, 974 F.2d 1050, 1059 (9th Cir.1992). A grant of summary judgment should be affirmed only if the evidence, read in the light most favorable to the nonmoving party, demonstrates that there is no genuine issue as to any material fact, and the moving party is entitled to judgment as a matter of law. Fed.R.Civ.P. 56(c); McGuckin, 974 F.2d at 1059. To defeat a summary judgment motion, the nonmoving party must come forward with evidence sufficient to establish the existence of any elements that are essential to that party's case, and for which that party will bear the burden of proof at trial. Celotex Corp. v. Catrett, 477 U.S. 317, 322 (1986).

A. Antitrust Injury

"[T]o establish a claim under Sec. 1 of the Sherman Act, the plaintiff must show 1) that there was a contract, combination, or conspiracy; 2) that the agreement unreasonably restrained trade under either a per se rule of illegality or a rule of reason analysis; and 3) that the restraint affected interstate commerce." Bhan v. NME Hosps., Inc., 929 F.2d 1404, 1410 (9th Cir.), cert. denied, 112 S.Ct. 617 (1991). In cases, such as this one, where plaintiff does not allege defendants have engaged in practices which are presumptively illegal per se, we apply the "rule of reason" test to determine whether a practice unreasonably restrains trade. Id. at 1410-13, McGlinchy v. Shell Chemical Co., 845 F.2d 802, 811 & n. 3 (9th Cir.1988).

Under this test, plaintiff must demonstrate that defendants caused an actual "injury to competition, beyond the impact on the [plaintiff]," within a particular geographic and product market. Austin v. McNamara, 979 F.2d 728, 738 (9th Cir.1992). Plaintiff may demonstrate such an injury by showing "detriment to consumers in the market in terms of price, quality and availability of the product at issue." Datagate, Inc. v. Hewlett-Packard Co., 672 F.Supp. 1288, 1291 (N.D.Cal.1987). Plaintiff must also demonstrate an anti-competitive injury to prevail on a claim under Sec. 2 of the Sherman Act. McGlinchy 845 F.2d at 811.

Here, the parties agreed that the market at issue was the practice of pediatrics with specialization in intensive care nursery treatment in Stanislaus County. Kumar failed to offer any evidence of injury to competition within this market, such as diminishment in the quality of neonatal care or an anti-competitive increase in the price of neonatal services. See Jefferson Parish Hosp. Dist. No. 2 v. Hyde, 466 U.S. 2, 31 n. 52 (1983). We note that to the extent Kumar presented evidence of defendants' misconduct in relation to his loss of staff privileges at MCH, he failed to demonstrate a detrimental effect on competition in the market. See Austin, 979 F.2d at 739. In contrast, defendants submitted evidence in the form of affidavits showing that both the number of patients admitted to the intensive care unit at MCH and the number of doctors performing neonatology services there have increased since Kumar left MCH. This evidence negates the existence of an antitrust injury. See Oksanen v. Page Memorial Hosp., 945 F.2d 696, 709 (4th Cir.1991). Because Kumar failed to offer any evidence of an antitrust injury, the district court correctly concluded that there was no genuine issue of material fact precluding summary judgment for the defendants.1

B. Discovery Pursuant to Fed.R.Civ.P. 56

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Cite This Page — Counsel Stack

Bluebook (online)
42 F.3d 1400, 1994 U.S. App. LEXIS 39478, 1994 WL 659031, Counsel Stack Legal Research, https://law.counselstack.com/opinion/kumar-v-national-medical-enterprises-inc-ca9-1994.